How can the biopharma industry take control of its value chain emissions?
GSK has set ambitious goals to reduce carbon, water and waste across its value chain –from the sourcing of raw materials and the impacts of its own labs and factories, to the use and disposal of its products by patients and consumers.
As a global pharmaceutical company with a mission to help people do more, feel better and live longer, the rationale for an environmentally conscious approach is clear. Environmental challenges like climate change and deforestation exacerbate health issues and undermine efforts to overcome inequalities around the world. To achieve its environmental objectives, GSK needed to measure, allocate and track emissions to isolate specific hotspot areas across the value chain.
GSK wanted to create a consistent approach to calculating the full carbon impact of its value chain. In 2014, it turned to the Carbon Trust to create a tool in line with international standards. Since then, we have been working on an annual basis to update the tool and integrate the results within a Power BI dashboard to support GSK in tracking their emission reductions on a yearly basis.